JSM 2013 Home
Online Program Home
My Program

Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.

Activity Details


487 Wed, 8/7/2013, 8:30 AM - 10:20 AM CC-512c
Challenges in the Evaluation of Biologics — Contributed Papers
Biopharmaceutical Section , Biometrics Section
Chair(s): Judy Li, FDA
8:35 AM Determination of Bioassay Cut Point Using Confidence Limit of Percentile Meiyu Shen, FDA ; Xiaoyu Dong, FDA ; Youngsook Jeon, FDA ; Yi Tsong, FDA
9:05 AM Modeling and Interpretation of Vaccine Cross-Over Clinical Trials Data Scott Patterson ; Byron Jones, Novartis Pharma AG ; Michael Kenward, University of London
9:20 AM Two-Threshold Model for Immunological Correlates of Protection Hongbo Lin ; Fabrice Bailleux, Sanofi Pasteur ; Xuan Chen, Sanofi Pasteur ; Kamal Desai, Imperial College ; Andrew Dunning, Sanofi Pasteur
9:35 AM Predicting Vaccine Efficacy Based on Associations Among Disease, Immune Responses, and Treatment Lihan Yan, FDA
9:50 AM Assessment of Biosimilar Products Using a Biosimilarity Index Based on a Tolerance Interval Approach Chinfu Hsiao, National Health Research Institutes ; Hsiao-Hui Tsou, National Health Research Institutes
10:05 AM Simultaneous Joint and Marginal Models Approach for Testing Multivariate Binomial Data — Shuling Liu, Emory University ; Kerry Go, Sanofi Pasteur ; Manoj Thakur, Sanofi Pasteur



2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.